tiprankstipranks
PolyPid Ltd. (PYPD)
NASDAQ:PYPD
US Market
PYPD
PolyPid
RESEARCH TOOLSreports
Want to see PYPD full AI Analyst Report?

PolyPid (PYPD) Stock News & Sentiment

410 Followers
PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
Premium
Company Announcements
PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
1M ago
6K
PYPD
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
Premium
TipRanks Newswire
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
1M ago
APLS
PYPD
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
Premium
TipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
2M ago
CING
OVID
PolyPid Earnings Call Flags Big 2026 Catalyst
Premium
Company Announcements
PolyPid Earnings Call Flags Big 2026 Catalyst
3M ago
PYPD
PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
Premium
Ratings
PolyPid: Advancing D-PLEX100 De-Risks Platform Potential and Creates Compelling Buy-Rated Risk-Reward
3M ago
PYPD
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
PolyPid Ltd. (PYPD) Q4 Earnings Cheat Sheet
3M ago
PYPD
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
Premium
Company Announcements
PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation
4M ago
6K
PYPD
More PYPD News >

PYPD News on the Web

Roth MKM Remains a Buy on PolyPid (PYPD)
TipRanks News
Bullish
PolyPid To Present New Phase 3 SHIELD II Data On D-PLEX100 At ESCMID 2026
rttnews
Bullish
PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
PolyPid's Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape ...
GuruFocus News
Bullish
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Axsome Therapeutics (AXSM)
TipRanks News
Neutral
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
GuruFocus News
Bullish

News Score - Last 7 Days

Positive
PYPD
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PYPD’s Media Buzz Sentiment?
2 articles about PYPD were published this week. In an average week, 2.25 articles are published.
    What is PYPD’s weekly average amount of articles?
    In an average week, 2.25 articles about PYPD are published.
      What is PYPD’s News Sentiment?
      100% of articles about PYPD were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week